Pitch Me a Stock (Long)

1. Recommendation up front — 'I'd go long [Company]. It trades at ~$X; I think it's worth ~$Y, roughly 30-40% upside over 12-18 months.' 2) Thesis (2-3 pillars) — the core reasons it's undervalued (e.g., underappreciated margin expansion, a misunderstood segment, secular tailwind). 3) Variant perception — why is this opportunity available? What does the market believe that's wrong? 4) Catalysts — earnings beats, a spinoff, new product, capital return, that will force a re-rating. 5) Valuation — your target via comps or a DCF, framed as upside vs. downside (asymmetry). 6) Risks + mitigants.

A pitch that just says 'good company, growing, cheap' is a screen, not a thesis. The interviewer is listening for: why is the stock mispriced right now? Common valid reasons: the market is over-extrapolating a temporary problem, a segment is buried inside a larger company, sell-side estimates are too low, a one-time charge is masking real earnings power, or sentiment is driven by a headline that doesn't change the long-term economics. If everyone already agrees with you, there's no edge.

Frame the upside/downside, not just a target. The best longs are asymmetric: ~3:1 or better upside to downside. Quantify it: 'In my base case it's worth $Y (35% up); even in a bear case where margins don't expand, downside is only ~10% because it's already cheap on EV/EBITDA vs. peers.' Cite the specific multiple or DCF assumption — vague 'it's undervalued' gets dinged. Showing a margin of safety signals real investing instinct.

Always volunteer 2-3 real risks (competition, regulation, key-customer concentration, execution) and how you'd monitor or mitigate them — pretending there's no downside kills credibility. Expect follow-ups: 'What's the bear case?', 'What would make you sell?', 'How does this compare to peers?', 'What's the consensus view and why are you different?' Know your numbers cold: revenue, growth, margins, the multiple, net debt.

Choose a mid-to-large cap, liquid, well-covered company you genuinely understand — not an obscure micro-cap you can't defend. Avoid the firm's own holdings or anything binary (single-drug biotech) unless you can defend it deeply. Have 2-3 names ready in different sectors. Know the current price and recent stock move; being wrong on the share price instantly undercuts you.